The vaccine industry has undergone an unprecedented transformation in the last 5 years, driven by significant technological advancements and a renewed global focus on public health and immunization.
Breakthroughs in multiple areas like HSV, RSV, and COVID-19 have emerged. The rise of mRNA vaccines and innovations in self-administration methods, such as microneedle patches and nasal vaccines, are improving accessibility and compliance. Advances in DNA-based vaccines, viral vectors, and AI-driven development are accelerating production timelines.
As the demand for effective vaccines grows, competition among manufacturers intensifies, pushing the need for continuous innovation. But which innovations truly move the needle? That depends on what healthcare professionals.
Enter your information below to instantly access the full white paper:
